Profile banner
Lauren Broffman

Lauren Broffman

Director of Real World Evidence and Clinical Research

New York, New York

Summary

Lauren Broffman is a distinguished expert in Real World Evidence (RWE) and clinical research, with a strong focus on telehealth and health policy. Her work at Ro, where she has held several leadership roles including Director of Real World Evidence and Director of Clinical Research, involves leveraging data to improve healthcare outcomes, particularly in areas like weight management with GLP-1 medications and patient-reported outcomes in virtual care. wiley+2
She has extensively researched the effectiveness and safety of telehealth platforms, including comparative studies on asynchronous versus synchronous virtual care for various conditions. Her publications demonstrate a commitment to advancing evidence-based approaches in telemedicine and understanding patient experiences in digital health environments. jmir+2
Lauren also has a background in health services research, stemming from her time at Providence Health & Services and her PhD in Health Policy and Management from NYU Robert F. Wagner Graduate School of Public Service. Her early work included qualitative studies on mental health and substance use treatment gaps in rural populations, highlighting her broad expertise in public health challenges and healthcare delivery. providence+2

Work

Education

Writing

Real‐World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study

December 1, 2023

This study assessed weight and safety outcomes in a large national cohort of patients with overweight and obesity treated with GLP-1 medications via telehealth, finding that semaglutide treatment via telehealth can achieve trial-level weight loss with similar safety profiles.

Favicon imageonlinelibrary.wiley.com

The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial

November 1, 2023

This research evaluated an automated patient-reported outcome data collection and adverse event surveillance tool, finding that prompting patients to report side effects and outcomes has the potential to improve quality of care in virtual treatment.

Favicon imagepubmed.ncbi.nlm.nih.gov

Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing

January 1, 2023

This study proposes and tests an integrated model to examine the implementation of HIV testing among drug abuse treatment organizations using structural equation modeling.

Favicon imagesciencedirect.com

Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study

January 1, 2022

This study explored whether asynchronous care leads to different patient outcomes in the form of medication-related adverse events compared to synchronous virtual care, specifically for erectile dysfunction, finding that asynchronous care can offer the same level of safety in prescribing in certain circumstances.

Favicon imageformative.jmir.org

Understanding Treatment Gaps for Mental Health, Alcohol, and Drug Use in South Dakota: A Qualitative Study of Rural Perspectives.

January 1, 2017

This qualitative study explored how rural participants with behavioral health conditions pursue and receive care, and how these factors differed across American Indian and geographic subpopulations in South Dakota.

Favicon imagedigitalcommons.providence.org